Review



anti khdrbs1 sam68  (Bethyl)


Bioz Verified Symbol Bethyl is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Bethyl anti khdrbs1 sam68
    Anti Khdrbs1 Sam68, supplied by Bethyl, used in various techniques. Bioz Stars score: 93/100, based on 14 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti khdrbs1 sam68/product/Bethyl
    Average 93 stars, based on 14 article reviews
    anti khdrbs1 sam68 - by Bioz Stars, 2026-04
    93/100 stars

    Images



    Similar Products

    93
    TargetMol recombinant his p62
    Recombinant His P62, supplied by TargetMol, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant his p62/product/TargetMol
    Average 93 stars, based on 1 article reviews
    recombinant his p62 - by Bioz Stars, 2026-04
    93/100 stars
      Buy from Supplier

    93
    Proteintech khdrbs1
    Khdrbs1, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/khdrbs1/product/Proteintech
    Average 93 stars, based on 1 article reviews
    khdrbs1 - by Bioz Stars, 2026-04
    93/100 stars
      Buy from Supplier

    93
    Bethyl anti khdrbs1 sam68
    Anti Khdrbs1 Sam68, supplied by Bethyl, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti khdrbs1 sam68/product/Bethyl
    Average 93 stars, based on 1 article reviews
    anti khdrbs1 sam68 - by Bioz Stars, 2026-04
    93/100 stars
      Buy from Supplier

    93
    Bethyl khdrbs1 sam68
    Khdrbs1 Sam68, supplied by Bethyl, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/khdrbs1 sam68/product/Bethyl
    Average 93 stars, based on 1 article reviews
    khdrbs1 sam68 - by Bioz Stars, 2026-04
    93/100 stars
      Buy from Supplier

    90
    Thermo Fisher silencertm select khdrbs1 sirna
    Silencertm Select Khdrbs1 Sirna, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/silencertm select khdrbs1 sirna/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    silencertm select khdrbs1 sirna - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    91
    OriGene flag sam68
    Flag Sam68, supplied by OriGene, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/flag sam68/product/OriGene
    Average 91 stars, based on 1 article reviews
    flag sam68 - by Bioz Stars, 2026-04
    91/100 stars
      Buy from Supplier

    93
    Proteintech anti khdrbs1
    Anti Khdrbs1, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti khdrbs1/product/Proteintech
    Average 93 stars, based on 1 article reviews
    anti khdrbs1 - by Bioz Stars, 2026-04
    93/100 stars
      Buy from Supplier

    91
    OriGene human sam68
    a Immunoblot analysis of <t>Sam68</t> and FADD after CRISPR-mediated knockout (KO) in the MCF-10A background. TWT = Targeted Wild-Type. b Quantification of DNA release from MCF-10A KO cell lines in culture. Individual cell lines shown, with data representing mean fold change ± SEM internally normalized to cell concentration for each cell line and then normalized to control; n = 3 biologically independent samples. Electropherograms were individually run at least n = 3 times and representative traces were selected. c Quantification of DNA release from Sam68 KO MCF-10A cell lines rescued by Sam68-GFP overexpression. Parental and TWT were grouped and labeled control, and two Sam68 KO3 and KO4 were grouped. Data represent mean fold change ± SEM internally normalized to cell concentration for each cell line and then normalized to control; n = 4 for all lines except n = 3 for Sam68 TWT before combining. Electropherograms were individually run at least n = 3 times and representative traces were selected. d Quantification of DNA release from FADD KO MCF-10A cell lines rescued by FADD-GFP overexpression. Parental and TWT were grouped and labeled control, and two FADD KO cell lines were grouped. Data represent mean fold change ± SEM internally normalized to cell concentration for each cell line and then normalized to control; n = 3 for all GFP-expressing lines and n = 4 for each FADD-GFP expressing line before combining. Electropherograms were individually run at least n = 3 times and representative traces were selected. e Cell growth assay of KO MCF-10A cell lines. Parental and TWT were grouped and labeled control. All four Sam68 KO cell lines and both FADD KO cell lines are respectively grouped. Data represent mean cell concentration ± SEM; n = 3 for each cell line before combining. f Annexin V and Propidium Iodide (PI) assay of KO MCF-10A cell lines. Parental and TWT were grouped and labeled control. All four Sam68 KO cell lines and both FADD KO cell were grouped, respectively. Data represent mean signal (RFU for PI; RLU for Annexin) ± SEM internally normalized to cell concentration for each cell line and then normalized to control; n = 6 biologically independent samples for each cell line before combining. g Cytotoxic assay of MCF-10A KO panel treated with 1 ng/mL TRAIL ligand. Parental and TWT were grouped and labeled control. All four Sam68 mutant cell lines and both FADD mutant cell lines were grouped, respectively. Data represent mean percent survival ± SEM as normalized to vehicle of each cell line condition; n = 3 biologically independent samples for each cell line before combining. h Quantification of DNA release from MCF-10A KO panel treated with 1 ng/mL TRAIL ligand. Parental and TWT were grouped and labeled control. All four Sam68 mutant cell lines and both FADD mutant cell lines were respectively grouped. Data represent mean fold change ± SEM internally normalized to cell concentration for each cell line and then normalized to control; n = 3 biologically independent samples for each cell line before combining. i Quantification of DNA release from MCF-10A KO cell lines treated with 20 μg/mL ZVAD-FM-K. Parental MCF-10As, Sam68 KO3/4 mutant cell lines, and both FADD mutant cell lines were respectively grouped. Data represent mean fold change ± SEM in DNA release internally normalized to cell concentration for each cell line and then normalized to control vehicle; n = 3 biologically independent samples for all untreated lines and FADD KO1, n = 4 for treated lines for each cell line before combining. All statistics were ANOVA with Dunnett’s multiple comparison test at endpoint.
    Human Sam68, supplied by OriGene, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human sam68/product/OriGene
    Average 91 stars, based on 1 article reviews
    human sam68 - by Bioz Stars, 2026-04
    91/100 stars
      Buy from Supplier

    Image Search Results


    a Immunoblot analysis of Sam68 and FADD after CRISPR-mediated knockout (KO) in the MCF-10A background. TWT = Targeted Wild-Type. b Quantification of DNA release from MCF-10A KO cell lines in culture. Individual cell lines shown, with data representing mean fold change ± SEM internally normalized to cell concentration for each cell line and then normalized to control; n = 3 biologically independent samples. Electropherograms were individually run at least n = 3 times and representative traces were selected. c Quantification of DNA release from Sam68 KO MCF-10A cell lines rescued by Sam68-GFP overexpression. Parental and TWT were grouped and labeled control, and two Sam68 KO3 and KO4 were grouped. Data represent mean fold change ± SEM internally normalized to cell concentration for each cell line and then normalized to control; n = 4 for all lines except n = 3 for Sam68 TWT before combining. Electropherograms were individually run at least n = 3 times and representative traces were selected. d Quantification of DNA release from FADD KO MCF-10A cell lines rescued by FADD-GFP overexpression. Parental and TWT were grouped and labeled control, and two FADD KO cell lines were grouped. Data represent mean fold change ± SEM internally normalized to cell concentration for each cell line and then normalized to control; n = 3 for all GFP-expressing lines and n = 4 for each FADD-GFP expressing line before combining. Electropherograms were individually run at least n = 3 times and representative traces were selected. e Cell growth assay of KO MCF-10A cell lines. Parental and TWT were grouped and labeled control. All four Sam68 KO cell lines and both FADD KO cell lines are respectively grouped. Data represent mean cell concentration ± SEM; n = 3 for each cell line before combining. f Annexin V and Propidium Iodide (PI) assay of KO MCF-10A cell lines. Parental and TWT were grouped and labeled control. All four Sam68 KO cell lines and both FADD KO cell were grouped, respectively. Data represent mean signal (RFU for PI; RLU for Annexin) ± SEM internally normalized to cell concentration for each cell line and then normalized to control; n = 6 biologically independent samples for each cell line before combining. g Cytotoxic assay of MCF-10A KO panel treated with 1 ng/mL TRAIL ligand. Parental and TWT were grouped and labeled control. All four Sam68 mutant cell lines and both FADD mutant cell lines were grouped, respectively. Data represent mean percent survival ± SEM as normalized to vehicle of each cell line condition; n = 3 biologically independent samples for each cell line before combining. h Quantification of DNA release from MCF-10A KO panel treated with 1 ng/mL TRAIL ligand. Parental and TWT were grouped and labeled control. All four Sam68 mutant cell lines and both FADD mutant cell lines were respectively grouped. Data represent mean fold change ± SEM internally normalized to cell concentration for each cell line and then normalized to control; n = 3 biologically independent samples for each cell line before combining. i Quantification of DNA release from MCF-10A KO cell lines treated with 20 μg/mL ZVAD-FM-K. Parental MCF-10As, Sam68 KO3/4 mutant cell lines, and both FADD mutant cell lines were respectively grouped. Data represent mean fold change ± SEM in DNA release internally normalized to cell concentration for each cell line and then normalized to control vehicle; n = 3 biologically independent samples for all untreated lines and FADD KO1, n = 4 for treated lines for each cell line before combining. All statistics were ANOVA with Dunnett’s multiple comparison test at endpoint.

    Journal: Communications Biology

    Article Title: An in vitro CRISPR screen of cell-free DNA identifies apoptosis as the primary mediator of cell-free DNA release

    doi: 10.1038/s42003-024-06129-1

    Figure Lengend Snippet: a Immunoblot analysis of Sam68 and FADD after CRISPR-mediated knockout (KO) in the MCF-10A background. TWT = Targeted Wild-Type. b Quantification of DNA release from MCF-10A KO cell lines in culture. Individual cell lines shown, with data representing mean fold change ± SEM internally normalized to cell concentration for each cell line and then normalized to control; n = 3 biologically independent samples. Electropherograms were individually run at least n = 3 times and representative traces were selected. c Quantification of DNA release from Sam68 KO MCF-10A cell lines rescued by Sam68-GFP overexpression. Parental and TWT were grouped and labeled control, and two Sam68 KO3 and KO4 were grouped. Data represent mean fold change ± SEM internally normalized to cell concentration for each cell line and then normalized to control; n = 4 for all lines except n = 3 for Sam68 TWT before combining. Electropherograms were individually run at least n = 3 times and representative traces were selected. d Quantification of DNA release from FADD KO MCF-10A cell lines rescued by FADD-GFP overexpression. Parental and TWT were grouped and labeled control, and two FADD KO cell lines were grouped. Data represent mean fold change ± SEM internally normalized to cell concentration for each cell line and then normalized to control; n = 3 for all GFP-expressing lines and n = 4 for each FADD-GFP expressing line before combining. Electropherograms were individually run at least n = 3 times and representative traces were selected. e Cell growth assay of KO MCF-10A cell lines. Parental and TWT were grouped and labeled control. All four Sam68 KO cell lines and both FADD KO cell lines are respectively grouped. Data represent mean cell concentration ± SEM; n = 3 for each cell line before combining. f Annexin V and Propidium Iodide (PI) assay of KO MCF-10A cell lines. Parental and TWT were grouped and labeled control. All four Sam68 KO cell lines and both FADD KO cell were grouped, respectively. Data represent mean signal (RFU for PI; RLU for Annexin) ± SEM internally normalized to cell concentration for each cell line and then normalized to control; n = 6 biologically independent samples for each cell line before combining. g Cytotoxic assay of MCF-10A KO panel treated with 1 ng/mL TRAIL ligand. Parental and TWT were grouped and labeled control. All four Sam68 mutant cell lines and both FADD mutant cell lines were grouped, respectively. Data represent mean percent survival ± SEM as normalized to vehicle of each cell line condition; n = 3 biologically independent samples for each cell line before combining. h Quantification of DNA release from MCF-10A KO panel treated with 1 ng/mL TRAIL ligand. Parental and TWT were grouped and labeled control. All four Sam68 mutant cell lines and both FADD mutant cell lines were respectively grouped. Data represent mean fold change ± SEM internally normalized to cell concentration for each cell line and then normalized to control; n = 3 biologically independent samples for each cell line before combining. i Quantification of DNA release from MCF-10A KO cell lines treated with 20 μg/mL ZVAD-FM-K. Parental MCF-10As, Sam68 KO3/4 mutant cell lines, and both FADD mutant cell lines were respectively grouped. Data represent mean fold change ± SEM in DNA release internally normalized to cell concentration for each cell line and then normalized to control vehicle; n = 3 biologically independent samples for all untreated lines and FADD KO1, n = 4 for treated lines for each cell line before combining. All statistics were ANOVA with Dunnett’s multiple comparison test at endpoint.

    Article Snippet: Lentiviral expression vectors with CMV promoters driving GFP-tagged human Sam68 and FADD were purchased from Origene (PS100093, RC200263L4, RC201805L4).

    Techniques: Western Blot, CRISPR, Knock-Out, Concentration Assay, Control, Over Expression, Labeling, Expressing, Growth Assay, Mutagenesis, Comparison

    a Quantification of DNA release from MDA-MB-231, MDA-MB-468, and HCT116 cancer cell lines with overexpression of GFP-tagged Sam68 or FADD. Data represent mean fold change ± SEM in DNA release normalized to cell concentration for each cell line, then overall to GFP control; n = 4 biologically independent samples. b Fragmentation pattern of MDA-MB-231, MDA-MB-468, and HCT116 cancer cell lines with overexpression of GFP-tagged Sam68 and FADD. Electropherograms were individually run at least n = 3 times and representative traces were selected. c Quantification of Annexin V signal from MDA-MB-231, MDA-MB-468, and HCT116 cancer cell lines with overexpression of GFP-tagged Sam68 and FADD. Data represent mean fold change ± SEM in RLU signal normalized to cell concentration at collection for each cell line, then overall to GFP control; n = 4 biologically independent samples for MDA-MB-231 and HCT116, n = 6 for MDA-MB-468. d Quantification of DNA release from MDA-MB-231, MDA-MB-468, and HCT116 cancer cell lines treated with TRAIL ligand. Data represent mean fold change ± SEM in DNA release normalized to cell concentration for each treatment, then overall to vehicle control; n = 4 biologically independent samples. e Fragmentation pattern of MDA-MB-231, MDA-MB-468, and HCT116 cancer cell lines treated with TRAIL ligand. Electropherograms were individually run at least n = 3 times and representative traces were selected. f Quantification of Annexin V signal from MDA-MB-231, MDA-MB-468, and HCT116 cancer cell lines treated with TRAIL Ligand. Data represent mean fold change ± SEM RLU signal normalized to cell concentration for each treatment, then overall to vehicle control; n = 6 biologically independent samples. g Quantification of Propidium Iodide signal from MDA-MB-231, MDA-MB-468, and HCT116 cancer cell lines treated with TRAIL Ligand. Data represent mean fold change ± SEM RFU signal normalized to cell concentration for each treatment, then overall to vehicle control; n = 6 biologically independent samples. All statistics were ANOVA with Dunnett’s multiple comparison test at endpoint.

    Journal: Communications Biology

    Article Title: An in vitro CRISPR screen of cell-free DNA identifies apoptosis as the primary mediator of cell-free DNA release

    doi: 10.1038/s42003-024-06129-1

    Figure Lengend Snippet: a Quantification of DNA release from MDA-MB-231, MDA-MB-468, and HCT116 cancer cell lines with overexpression of GFP-tagged Sam68 or FADD. Data represent mean fold change ± SEM in DNA release normalized to cell concentration for each cell line, then overall to GFP control; n = 4 biologically independent samples. b Fragmentation pattern of MDA-MB-231, MDA-MB-468, and HCT116 cancer cell lines with overexpression of GFP-tagged Sam68 and FADD. Electropherograms were individually run at least n = 3 times and representative traces were selected. c Quantification of Annexin V signal from MDA-MB-231, MDA-MB-468, and HCT116 cancer cell lines with overexpression of GFP-tagged Sam68 and FADD. Data represent mean fold change ± SEM in RLU signal normalized to cell concentration at collection for each cell line, then overall to GFP control; n = 4 biologically independent samples for MDA-MB-231 and HCT116, n = 6 for MDA-MB-468. d Quantification of DNA release from MDA-MB-231, MDA-MB-468, and HCT116 cancer cell lines treated with TRAIL ligand. Data represent mean fold change ± SEM in DNA release normalized to cell concentration for each treatment, then overall to vehicle control; n = 4 biologically independent samples. e Fragmentation pattern of MDA-MB-231, MDA-MB-468, and HCT116 cancer cell lines treated with TRAIL ligand. Electropherograms were individually run at least n = 3 times and representative traces were selected. f Quantification of Annexin V signal from MDA-MB-231, MDA-MB-468, and HCT116 cancer cell lines treated with TRAIL Ligand. Data represent mean fold change ± SEM RLU signal normalized to cell concentration for each treatment, then overall to vehicle control; n = 6 biologically independent samples. g Quantification of Propidium Iodide signal from MDA-MB-231, MDA-MB-468, and HCT116 cancer cell lines treated with TRAIL Ligand. Data represent mean fold change ± SEM RFU signal normalized to cell concentration for each treatment, then overall to vehicle control; n = 6 biologically independent samples. All statistics were ANOVA with Dunnett’s multiple comparison test at endpoint.

    Article Snippet: Lentiviral expression vectors with CMV promoters driving GFP-tagged human Sam68 and FADD were purchased from Origene (PS100093, RC200263L4, RC201805L4).

    Techniques: Over Expression, Concentration Assay, Control, Comparison